Single center analysis of mycophenolate mofetil and neoral/prednisone therapy for prophylaxis of rejection in African-American and caucasian transplant recipients
Open Access
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 338-339
- https://doi.org/10.1016/s0041-1345(96)00295-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAFT OUTCOME IN RECIPIENTS OF FIRST CADAVER KIDNEY TRANSPLANTSTransplantation, 1992